NCT04376502 2025-01-03
Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma.
Baptist Health South Florida
Phase NA Terminated
Baptist Health South Florida
University of Kentucky
Abramson Cancer Center at Penn Medicine
H. Lee Moffitt Cancer Center and Research Institute